The International Longevity Centre – UK (ILC-UK) is organising its first major all day conference on The Future of Ageing, on Tuesday 24th November 2015 in London.

Confirmed speakers include:

  • Baroness Altmann (Minister or Pensions);
  • Professor Sir Mark Walport (Government Chief Scientific Adviser [GCSA] and Head of the Government Office for Science);
  • David Willetts (Executive Chair at Resolution Foundation, and former Minister of State [Department for Business, Innovation and Skills]);
  • Lord Filkin (Chair of the Centre for Ageing Better and Chair of the House of Lords Committee on Public Service and Demographic Change);
  • Paul Johnson (Director, Institute for Fiscal Studies);
  • Steve Groves (Chief Executive Officer at Partnership);
  • Professor Jane Elliott (Chief Executive, Economic and Social Research Council);
  • Steven Baxter (Partner, Hymans Robertson); and
  • Professor Ian Philp (Deputy Medical Director for Older People’s Care, Heart of England NHS Foundation Trust) will be speaking at the conference.

The conference will be chaired by Baroness Sally Greengross (Chief Executive, ILC-UK) and Lawrence Churchill (Trustee, ILC-UK).

ILC-UK are grateful to McCarthy & Stone and Partnership for their sponsorship of this conference.

Bookings can be made through the ILC-UK website.


See the latest ILC newsletter here. Sign up to our mailing list here.

The Communities and Local Government Committee has today released their report on Housing for Older People featuring oral and written evidence from Senior Research Fellow Dr Brian Beach.

The International Longevity Centre - UK hosts an annual full day conference to bring together representatives from Government, business, academia and civil society to discuss the Future of Ageing.

ILC-UK are recruiting for a Research Fellow to join the team

ILC-UK is recruiting for a Head of External Affairs to join the team

ILC-UK and the IFA express their concerns at the impact proposed changes to the childhood pneumococcal immunisation programme could have for rates of Invasive Pneumococcal Disease.